Skip to main content

Articles

Page 31 of 70

  1. The objective of the present study was to evaluate the effectiveness of postoperative radiotherapy after breast conserving surgery (BCS) in DCIS in a large patient population treated in clinical practice.

    Authors: Stefanie Corradini, Montserrat Pazos, Stephan Schönecker, Daniel Reitz, Maximilian Niyazi, Ute Ganswindt, Simone Schrodi, Michael Braun, Martin Pölcher, Sven Mahner, Nadia Harbeck, Jutta Engel and Claus Belka
    Citation: Radiation Oncology 2018 13:25
  2. To derive and exploit the optimal prescription isodose level (PIL) in inverse optimization of volumetric modulated arc radiotherapy (VMAT) as a potential approach to dose de–escalation in stereotactic body rad...

    Authors: Mark Chan, Matthew Wong, Ronnie Leung, Steven Cheung and Oliver Blanck
    Citation: Radiation Oncology 2018 13:24
  3. Radiation-induced parotid damage is a common complication in patients with nasopharyngeal carcinoma (NPC) treated with radiotherapy to head and neck region, which severely reduce the life quality of those pati...

    Authors: Nan Zhou, Chen Chu, Xin Dou, Weibo Chen, Jian He, Jing Yan, Zhengyang Zhou and Xiaofeng Yang
    Citation: Radiation Oncology 2018 13:22
  4. This study provides separate comparisons of 1 × 8 Gy to 5 × 4 Gy for metastatic epidural spinal cord compression (MESCC) in patients with poor, intermediate and favorable survival prognoses.

    Authors: Dirk Rades, Antonio J. Conde-Moreno, Jon Cacicedo, Theo Veninga, Barbara Segedin, Karmen Stanic, Volker Rudat and Steven E. Schild
    Citation: Radiation Oncology 2018 13:21
  5. To date, patients with glioblastoma still have a bad median overall survival rate despite radiation dose-escalation and combined modality treatment. Neurocognitive decline is a crucial adverse event which may ...

    Authors: Ann-Katrin Exeli, Daniel Kellner, Lukas Exeli, Phil Steininger, Frank Wolf, Felix Sedlmayer and Heinz Deutschmann
    Citation: Radiation Oncology 2018 13:20
  6. The purpose of the present study was to evaluate retrospectively the efficacy and safety of proton beam therapy for elderly patients (≥80 years of age) with non-small cell lung cancer.

    Authors: Takashi Ono, Tatsuya Nakamura, Hisashi Yamaguchi, Yusuke Azami, Kanako Takayama, Motohisa Suzuki, Hitoshi Wada, Yasuhiro Kikuchi, Masao Murakami and Kenji Nemoto
    Citation: Radiation Oncology 2018 13:19
  7. For the recurrence of head and neck cancer after operation and radiotherapy, the local control of radioactive seed implantation is good, and it has a certain palliative effect. This study aims to investigate t...

    Authors: Yuliang Jiang, Zhe Ji, Fuxin Guo, Ran Peng, Haitao Sun, Jinghong Fan, Shuhua Wei, Weiyan Li, Kai Liu, Jinghua Lei and Junjie Wang
    Citation: Radiation Oncology 2018 13:18
  8. To estimate the radiobiological parameters of three popular normal tissue complication probability (NTCP) models, which describe the dose-response relations of bladder regarding different acute urinary symptom...

    Authors: Panayiotis Mavroidis, Kevin A. Pearlstein, John Dooley, Jasmine Sun, Srinivas Saripalli, Shiva K. Das, Andrew Z. Wang and Ronald C. Chen
    Citation: Radiation Oncology 2018 13:17
  9. Despite screening campaigns, cervical cancers remain among the most prevalent malignancies and carry significant mortality, especially in developing countries. Most studies report outcomes of patients receivin...

    Authors: Sophie Espenel, Max-Adrien Garcia, Jane-Chloé Trone, Elodie Guillaume, Annabelle Harris, Amel Rehailia-Blanchard, Ming Yuan He, Sarra Ouni, Alexis Vallard, Chloé Rancoule, Majed Ben Mrad, Céline Chauleur, Guy De Laroche, Jean-Baptiste Guy, Pablo Moreno-Acosta and Nicolas Magné
    Citation: Radiation Oncology 2018 13:16

    The Correction to this article has been published in Radiation Oncology 2018 13:50

  10. The purpose of this study is to evaluate the tumor movement and accuracy of patient immobilization in stereotactic body radiotherapy of liver tumors with low pressure foil or abdominal compression.

    Authors: Constantin Dreher, Markus Oechsner, Michael Mayinger, Stefanie Beierl, Marciana-Nona Duma, Stephanie E. Combs and Daniel Habermehl
    Citation: Radiation Oncology 2018 13:15
  11. Endoscopic submucosal dissection (ESD) can be used as a less invasive treatment option for superficial esophageal cancer involving the muscularis mucosae (T1a-MM) or upper third of the submucosa (T1b-SM1). Add...

    Authors: Osamu Hisano, Takeshi Nonoshita, Hidenari Hirata, Tomonari Sasaki, Hideyuki Watanabe, Hiroaki Wakiyama, Minoru Ono, Saiji Ohga and Hiroshi Honda
    Citation: Radiation Oncology 2018 13:14
  12. The HyperArc VMAT (HA-VMAT) planning approach was newly developed to fulfill the demands of dose delivery for brain metastases stereotactic radiosurgery. We compared the dosimetric parameters of the HA-VMAT pl...

    Authors: Shingo Ohira, Yoshihiro Ueda, Yuichi Akino, Misaki Hashimoto, Akira Masaoka, Takero Hirata, Masayoshi Miyazaki, Masahiko Koizumi and Teruki Teshima
    Citation: Radiation Oncology 2018 13:13
  13. Some Chinese patients with esophageal squamous cell carcinomaare often treated with single-agent concurrent chemoradiotherapy. However, no results have been reported from randomized controlled clinical trials ...

    Authors: Jie Li, Youling Gong, Peng Diao, Qingmei Huang, Yixue Wen, Binwei Lin, Hongwei Cai, Honggang Tian, Bing He, Lanlan Ji, Ping Guo, Jidong Miao and Xiaobo Du
    Citation: Radiation Oncology 2018 13:12
  14. To identify optimization of dose distributions of target volumes and decrease of radiation doses to normal tissues during stereotactic body radiation therapy (SBRT) for pancreatic cancer with dose-limiting aut...

    Authors: Yangsen Cao, Xiaofei Zhu, Xiaoping Ju, Yongming Liu, Chunshan Yu, Yongjian Sun, Zhitao Dai, Xueling Guo and Huojun Zhang
    Citation: Radiation Oncology 2018 13:11
  15. Tumor immune-evasion and associated failure of immunotherapy can potentially be overcome by radiotherapy, which however also has detrimental effects on tumor-infiltrating and circulating lymphocytes (CL). We t...

    Authors: L. Basler, N. Andratschke, S. Ehrbar, M. Guckenberger and S. Tanadini-Lang
    Citation: Radiation Oncology 2018 13:10
  16. Children can experience distress when undergoing radiotherapy as a reaction to being scared of and unfamiliar with the procedure. The aim was to evaluate children’s experiences and responses towards an interve...

    Authors: Gunn Engvall, Viveca Lindh, Tara Mullaney, Tufve Nyholm, Jack Lindh and Charlotte Ångström-Brännström
    Citation: Radiation Oncology 2018 13:9
  17. In the original publication [1] two author names were missing the middle names. The corrected versions can be found in this Erratum.

    Authors: Andra V. Krauze, Albert Attia, Steve Braunstein, Michael Chan, Stephanie E. Combs, Rainer Fietkau, John Fiveash, John Flickinger, Anca Grosu, Steven Howard, Carsten Nieder, Maximilian Niyazi, Lindsay Rowe, Dee Dee Smart, Christina Tsien and Kevin Camphausen
    Citation: Radiation Oncology 2018 13:8

    The original article was published in Radiation Oncology 2017 12:194

  18. The aim of this study was to identify the long-term clinical outcome of definitive radiotherapy using three-dimensional conformal radiotherapy (3DCRT) for cervical esophageal squamous cell carcinoma (CESCC).

    Authors: Katsuyuki Sakanaka, Yuichi Ishida, Kota Fujii, Satoshi Itasaka, Shin’ichi Miyamoto, Takahiro Horimatsu, Manabu Muto and Takashi Mizowaki
    Citation: Radiation Oncology 2018 13:7
  19. The present work summarizes the research activities on radiation-induced late effects in the rat spinal cord carried out within the “clinical research group ion beam therapy” funded by the German Research Foun...

    Authors: Maria Saager, Peter Peschke, Thomas Welzel, Lifi Huang, Stephan Brons, Rebecca Grün, Michael Scholz, Jürgen Debus and Christian P. Karger
    Citation: Radiation Oncology 2018 13:5
  20. We evaluated dynamic changes in 18F–borono-L-phenylalanine (18F–BPA) uptake in unresectable, advanced, or recurrent squamous cell carcinoma of the head and neck (SCC) and malignant melanoma (MM) during boron neut...

    Authors: Takahiro Morita, Hiroaki Kurihara, Kenta Hiroi, Natsuki Honda, Hiroshi Igaki, Jun Hatazawa, Yasuaki Arai and Jun Itami
    Citation: Radiation Oncology 2018 13:4
  21. Malignant melanoma brain metastases (MBM) are the third most common cause for brain metastases (BM). Historically Whole-brain radiotherapy (WBRT) was considered the goldstandard of treatment even though melano...

    Authors: Harun Badakhshi, Fidelis Engeling, Volker Budach, Pirus Ghadjar, Sebastian Zschaeck and David Kaul
    Citation: Radiation Oncology 2018 13:3
  22. Due to their favorable physical and biological properties, helium ion beams are increasingly considered a promising alternative to proton beams for radiation therapy. Hence, this work aims at comparing in-silico ...

    Authors: Thomas Tessonnier, Andrea Mairani, Wenjing Chen, Paola Sala, Francesco Cerutti, Alfredo Ferrari, Thomas Haberer, Jürgen Debus and Katia Parodi
    Citation: Radiation Oncology 2018 13:2
  23. Patients with Echinoderm microtubule-associated protein-like 4 (EML4)-anaplastic lymphoma kinase (ALK) positive lung cancer are sensitive to ALK-kinase inhibitors. TAE684 is a potent second generation ALK inhi...

    Authors: Ying Dai, Quanxiang Wei, Christian Schwager, Janina Hanne, Cheng Zhou, Klaus Herfarth, Stefan Rieken, Kenneth E. Lipson, Jürgen Debus and Amir Abdollahi
    Citation: Radiation Oncology 2018 13:1
  24. Hypoxia-induced radioresistance constitutes a major obstacle for a curative treatment of cancer. The aim of this study was to investigate effects of photon and carbon ion irradiation in combination with inhibi...

    Authors: Carmen Klein, Ivana Dokic, Andrea Mairani, Stewart Mein, Stephan Brons, Peter Häring, Thomas Haberer, Oliver Jäkel, Astrid Zimmermann, Frank Zenke, Andree Blaukat, Jürgen Debus and Amir Abdollahi
    Citation: Radiation Oncology 2017 12:208
  25. Postoperative radiation (PORT) is an option for non-small cell lung cancer (NSCLC) patients with resectable stage IIIA pathological N2 status (pN2). For patients with PORT, this study aims to investigate the i...

    Authors: Siwei Wang, Zhifei Ma, Xiangbao Yang, Yajing Wang, Youtao Xu, Wenjia Xia, Rui Chen, Mantang Qiu, Feng Jiang, Rong Yin, Lin Xu and Keping Xu
    Citation: Radiation Oncology 2017 12:207
  26. Tumor Treating Fields (TTFields) are an anti-neoplastic treatment modality delivered via application of alternating electric fields using insulated transducer arrays placed directly on the skin in the region s...

    Authors: Moshe Giladi, Mijal Munster, Rosa S. Schneiderman, Tali Voloshin, Yaara Porat, Roni Blat, Katarzyna Zielinska-Chomej, Petra Hååg, Ze’ev Bomzon, Eilon D. Kirson, Uri Weinberg, Kristina Viktorsson, Rolf Lewensohn and Yoram Palti
    Citation: Radiation Oncology 2017 12:206
  27. Preclinical radiation biology has become increasingly sophisticated due to the implementation of advanced small animal image guided radiation platforms into laboratory investigation. These small animal radioth...

    Authors: Mihaela Ghita, Stephen J. McMahon, Hannah F. Thompson, Conor K. McGarry, Raymond King, Sarah O. S. Osman, Jonathan L. Kane, Amanda Tulk, Giuseppe Schettino, Karl T. Butterworth, Alan R. Hounsell and Kevin M. Prise
    Citation: Radiation Oncology 2017 12:204
  28. Pancreatic cancer, especially in case of locally advanced stage has a poor prognosis. Radiotherapy in general can lead to tumor volume reduction, but further improvements, such as ion beam therapy have to be p...

    Authors: Constantin Dreher, Daniel Habermehl, Oliver Jäkel and Stephanie E. Combs
    Citation: Radiation Oncology 2017 12:203
  29. Cisplatin and gemcitabine combined with conventional radiation therapy in the treatment of cervical cancer patients results in a favorable outcome but with excess toxicity. The purpose of this study was to eva...

    Authors: Nikola Cihoric, Alexandros Tsikkinis, Eugenia Vlaskou Badra, Markus Glatzer, Urban Novak, Amina Scherz, Mohamed Shelan, Ivan Soldatovic, Chittazhathu Kurian Kuruvilla Yojena, Daniel M. Aebersold and Kristina Lössl
    Citation: Radiation Oncology 2017 12:202
  30. Our previous studies showed that vasoconstrictor applied topically to rat skin minutes before irradiation completely prevented radiodermatitis. Here we report on a Phase IIa study of topically applied NG12-1 v...

    Authors: James F. Cleary, Bethany M. Anderson, Jens C. Eickhoff, Deepak Khuntia and William E. Fahl
    Citation: Radiation Oncology 2017 12:201
  31. The aim of this review is the critical appraisal of the current use of volumetric modulated arc therapy for the radiation therapy management of breast cancer. Both clinical and treatment planning studies were ...

    Authors: Luca Cozzi, Frank Lohr, Antonella Fogliata, Davide Franceschini, Fiorenza De Rose, A R Filippi, Gabriele Guidi, Valentina Vanoni and Marta Scorsetti
    Citation: Radiation Oncology 2017 12:200
  32. The internal mammary (IM) lymph node chain, along with the axillary nodal basin, is a first-echelon breast lymphatic draining site. A growing body of evidence supports irradiation of this region in node-positi...

    Authors: Sean Sachdev, Chelain R. Goodman, Erin Neuschler, Kapila Kalakota, Daniel Cutright, Eric D. Donnelly, John P. Hayes, Adam E. Prescott, Gianna Mirabelli and Jonathan B. Strauss
    Citation: Radiation Oncology 2017 12:199
  33. Peri-operative radiation of retroperitoneal sarcomas (RPS) is an important component of multidisciplinary treatment. All retrospective series thus far included patients treated with older radiation therapy (RT...

    Authors: Pippa F. Cosper, Jeffrey Olsen, Todd DeWees, Brian A. Van Tine, William Hawkins, Jeff Michalski and Imran Zoberi
    Citation: Radiation Oncology 2017 12:198
  34. The optimization of the management for elderly glioblastoma patients is crucial given the demographics of aging in many countries. We report the outcomes for a “real-life” patient cohort (i.e. unselected) comp...

    Authors: J. Biau, E. Chautard, E. De Schlichting, G. Dupic, B. Pereira, A. Fogli, M. Müller-Barthélémy, P. Dalloz, T. Khalil, A. F. Dillies, X. Durando, C. Godfraind and P. Verrelle
    Citation: Radiation Oncology 2017 12:197
  35. To compare organ-at-risk doses and setup reproducibility using the prone and supine orientations in volumetric modulated arc therapy (VMAT) for rectal cancer.

    Authors: Anthony Kim, Aliaksandr Karotki, Joe Presutti, Glen Gonzales, Shun Wong and William Chu
    Citation: Radiation Oncology 2017 12:180
  36. To evaluate the role of radiotherapy (RT) as an adjuvant or definitive treatment in primary tracheal adenoid cystic carcinoma (ACC) for local tumor control and survival.

    Authors: Hyoung Uk Je, Si Yeol Song, Dong Kwan Kim, Yong-Hee Kim, Seong-Yun Jeong, Geum Mun Back, Wonsik Choi, Su Ssan Kim, Seung-Il Park and Eun Kyung Choi
    Citation: Radiation Oncology 2017 12:196
  37. Heath-related quality of life (HRQoL) among survivors with unresectable locally-advanced non-small cell lung cancer (LA-NSCLC) treated with radiotherapy and chemotherapy still is not clear. The current study w...

    Authors: Juntao Ran, Jingbo Wang, Nan Bi, Wei Jiang, Zongmei Zhou, Zhouguang Hui, Jun Liang, Qinfu Feng and Luhua Wang
    Citation: Radiation Oncology 2017 12:195
  38. To investigate radiation oncologists’ opinions on important considerations to offering re-irradiation (re-RT) as a treatment option for recurrent glioma.

    Authors: Andra V. Krauze, Albert Attia, Steve Braunstein, Michael Chan, Stephanie E. Combs, Rainer Fietkau, John Fiveash, John Flickinger, Anca Grosu, Steven Howard, Carsten Nieder, Maximilian Niyazi, Lindsay Rowe, Dee Dee Smart, Christina Tsien and Kevin Camphausen
    Citation: Radiation Oncology 2017 12:194

    The Correction to this article has been published in Radiation Oncology 2018 13:8

  39. The rapid rise of particle therapy across the world necessitates evidence to justify its ever-increasing utilization. This narrative review summarizes the current status of these technologies on treatment of b...

    Authors: Sebastian Adeberg, Semi B. Harrabi, Vivek Verma, Denise Bernhardt, Nicole Grau, Jürgen Debus and Stefan Rieken
    Citation: Radiation Oncology 2017 12:193
  40. The purpose of this study was to investigate the differences in the dosimetric advantage of using intraoperatively built custom-linked (IBCL) seeds between permanent iodine-125 (I-125) seed implantation (PI) a...

    Authors: Katsumi Hirose, Masahiko Aoki, Mariko Sato, Hiroyoshi Akimoto, Yasuhiro Hashimoto, Atsushi Imai, Noritaka Kamimura, Hideo Kawaguchi, Yoshiomi Hatayama, Ichitaro Fujioka, Mitsuki Tanaka, Chikara Ohyama and Yoshihiro Takai
    Citation: Radiation Oncology 2017 12:192
  41. Despite mounting evidence for the use of re-irradiation (re-RT) in recurrent high grade glioma, optimal patient selection criteria for re-RT remain unknown. We present a novel scoring system based on radiobiol...

    Authors: Andra Valentina Krauze, Cord Peters, Jason Cheng, Holly Ning, Megan Mackey, Lindsay Rowe, Theresa Cooley-Zgela, Dee Dee Smart and Kevin Camphausen
    Citation: Radiation Oncology 2017 12:191
  42. Proton beam therapy is promising for the treatment of head and neck cancer (HNC), but it is sensitive to uncertainties in patient positioning and particle range. Studies have shown that the planning target vol...

    Authors: Macarena Cubillos-Mesías, Michael Baumann, Esther G. C. Troost, Fabian Lohaus, Steffen Löck, Christian Richter and Kristin Stützer
    Citation: Radiation Oncology 2017 12:190
  43. Intrafractional motion can be a substantial uncertainty in precision radiotherapy. Conventionally, the target volume is expanded to account for the motion. Couch-tracking is an alternative, where the patient i...

    Authors: Alexander Jöhl, Marta Bogowicz, Stefanie Ehrbar, Matthias Guckenberger, Stephan Klöck, Mirko Meboldt, Oliver Riesterer, Melanie Zeilinger, Marianne Schmid Daners and Stephanie Tanadini-Lang
    Citation: Radiation Oncology 2017 12:189
  44. The prognosis for patients with cervical or endometrial cancer has improved over the last decades. Thus, reducing therapy-related toxicity and impact on quality of life have become more and more important. Wit...

    Authors: N. Arians, K. Lindel, J. Krisam, K. Herfarth, D. Krug, S. Akbaba, J. Oelmann-Avendano and J. Debus
    Citation: Radiation Oncology 2017 12:188
  45. This work explores how the choice of prescription isodose line (IDL) affects the dose gradient, target coverage, and treatment time for Gamma Knife radiosurgery when a smaller shot is encompassed within a larg...

    Authors: Perry B. Johnson, Maria I. Monterroso, Fei Yang and Eric Mellon
    Citation: Radiation Oncology 2017 12:187
  46. In the original publication [1] the name of author Jeremy M. Aymard was spelled wrong. The original article was updated to rectify this error.

    Authors: Salman A. Eraj, Mona K. Jomaa, Crosby D. Rock, Abdallah S. R. Mohamed, Blaine D. Smith, Joshua B. Smith, Theodora Browne, Luke C. Cooksey, Bowman Williams, Brandi Temple, Kathryn E. Preston, Jeremy M. Aymard, Neil D. Gross, Randal S. Weber, Amy C. Hessel, Renata Ferrarotto…
    Citation: Radiation Oncology 2017 12:186

    The original article was published in Radiation Oncology 2017 12:150

  47. The skin is considered a critical organ at risk in carbon ion radiotherapy (CIRT) for locally advanced malignant bone and soft tissue tumors (MBSTs). The predictive factors for acute skin reactions after CIRT ...

    Authors: Yosuke Takakusagi, Jun-ichi Saitoh, Hiroki Kiyohara, Takahiro Oike, Shin-ei Noda, Tatsuya Ohno and Takashi Nakano
    Citation: Radiation Oncology 2017 12:185
  48. To investigate the advantage of concurrent chemotherapy with postoperative radiotherapy (RT) of oral squamous cell carcinoma (OSCC) in patients with three or more minor risk factors.

    Authors: Kang-Hsing Fan, Yen-Chao Chen, Chien-Yu Lin, Chung-Jan Kang, Li-Yu Lee, Shiang-Fu Huang, Chun-Ta Liao, Shu-Hang Ng, Hung-Ming Wang and Joseph Tung-Chieh Chang
    Citation: Radiation Oncology 2017 12:184

Annual Journal Metrics

  • 2022 Citation Impact
    3.6 - 2-year Impact Factor
    3.8 - 5-year Impact Factor
    1.370 - SNIP (Source Normalized Impact per Paper)
    1.037 - SJR (SCImago Journal Rank)

    2023 Speed
    16 days submission to first editorial decision for all manuscripts (Median)
    132 days submission to accept (Median)

    2023 Usage 
    1,958,690 downloads
    605 Altmetric mentions